Open AccessEfficacy and Safety of the Combination of Transarterial Chemoembolization with Camrelizumab plus Apatinib for Advanced Hepatocellular Carcinoma: A Retrospective Study of 38 Patients from a Single Center
Author(s) -
Jin-Xing Zhang,
Chen Yuxing,
ChunGao Zhou,
Jin Liu,
Sheng Liu,
HaiBin Shi,
QingQuan Zu
Publication year - 2022
Publication title -
canadian journal of gastroenterology and hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.921
H-Index - 65
eISSN - 2291-2797
pISSN - 2291-2789
DOI - 10.1155/2022/7982118
Subject(s) - apatinib , medicine , hepatocellular carcinoma , response evaluation criteria in solid tumors , adverse effect , single center , progression free survival , retrospective cohort study , oncology , overall survival , complete response , surgery , gastroenterology , progressive disease , chemotherapy
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom